• Profile
Close

Timeliness of DTaP-IPV-Hib vaccination and development of atopic dermatitis between 4 months and 1 year of age—Register-based cohort study

The Journal of Allergy and Clinical Immunology: In Practice Oct 29, 2020

Gehrt L, Rieckmann A, Kiraly N, et al. - This study was undertaken to determine if delayed vaccination against diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b (Diphtheria, Tetanus, acellular Pertussis – Inactivated Polio vaccine – Haemophilus influenzae type b [DTaP]) was correlated with a reduced risk of new cases of atopic dermatitis (AD) before age 1 year in Denmark. Nationwide registers were used to follow 883,160 children born in Denmark from 1997 to 2012. Four thousand eight hundred forty-seven (3.4%) of the 143,429 children with a delayed first dose of DTaP developed AD between age 4 months and 1 year, compared with 27,628 (3.7%) among 739,731 children not having delayed DTaP. The findings support the idea that delayed vaccination with DTaP is associated with decreased risk of developing new cases of AD after age 4 months. The dose-dependent relationship confirms the proof of a causal relationship. Some countries are implementing vaccination against maternal pertussis and delaying the first dose of DTaP, thereby offering a possibility for further testing of the hypothesis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay